AAP
GRDN

Arax Advisory Partners’s Guardian Pharmacy Services GRDN Stock Holding History

Arax Advisory Partners’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$30 – 4435
2025
Q4 		$30 Sell
1
-99
-99% -$2.8K ﹤0.01% 3995
2025
Q3 		$2.62K Buy
+100
New +$2.38K ﹤0.01% 3046

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Arax Advisory Partners's GRDN Position: Q1 2026 in Review

Arax Advisory Partners sold out of Guardian Pharmacy Services (GRDN) in Q1 2026, closing a stake of 1 share — an estimated $30 sold.

Arax Advisory Partners first reported a position in GRDN in Q3 2025 and held it in 2 quarters. The position peaked at $2.62K in Q3 2025. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • Arax Advisory Partners reported no remaining Guardian Pharmacy Services position as of Q1 2026 after selling out during the quarter.
  • Arax Advisory Partners sold 1 Guardian Pharmacy Services share in Q1 2026, an estimated $30.
  • Arax Advisory Partners first reported a position in Guardian Pharmacy Services in Q3 2025 and held it in 2 quarters.
  • Arax Advisory Partners's Guardian Pharmacy Services position peaked at $2.62K in Q3 2025.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.